LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...
Zacks.com on MSN6d
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag EstimatesCollegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback